Cas:50741-37-2 1,2,3,4-TETRAHYDROQUINOLINE-8-CARBONITRILE manufacturer & supplier

We serve Chemical Name:1,2,3,4-TETRAHYDROQUINOLINE-8-CARBONITRILE CAS:50741-37-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

1,2,3,4-TETRAHYDROQUINOLINE-8-CARBONITRILE

Chemical Name:1,2,3,4-TETRAHYDROQUINOLINE-8-CARBONITRILE
CAS.NO:50741-37-2
Synonyms:1,2,3,4-tetrahydroquinoline-8-carbonitrile
Molecular Formula:C10H10N2
Molecular Weight:158.20000
HS Code:2933499090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:35.82000
Exact Mass:158.08400
LogP:2.05438

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 1,2,3,4-tetrahydroquinoline-8-carbonitrile chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1,2,3,4-tetrahydroquinoline-8-carbonitrile physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1,2,3,4-tetrahydroquinoline-8-carbonitrile Use and application,1,2,3,4-tetrahydroquinoline-8-carbonitrile technical grade,usp/ep/jp grade.


Related News: The development of various enabling technologies has been critical in expanding the potential of biocatalytic processing, as well as in promoting its uptake across the pharmaceutical industry. 2-(5-((S)-1-(2-amino-2-methylpropanamido)-2-(benzyloxy)ethyl)-1H-tetrazol-1-yl)ethyl (R)-3-((1-phenylcyclopropane-1-carbonyl)oxy)pyrrolidine-1-carboxylate manufacturers The client needed full development and product readiness with an extremely short supply of the API. In addition, the scale-up batch was small because of the low volume of product demands of their orphan drug. butyl 3′-oxospiro[cyclopropane-1,2′-indole]-1′-carboxylate suppliers Earlier this year, the company revealed it had broken ground on a 38,000-square-foot commercial cell therapy plant in Lexington, Massachusetts, which is about 10 miles from downtown Boston. Takeda says the new $84 million plant will be used to make cell therapies for cancers and other diseases. 1-(5-acetyl-4-methyl-thiazol-2-yl)-3-{(3R,4R)-1-(2-diethylamino-ethyl)-3-[(S)-3-(4-fluoro-benzyl)-piperidin-1-ylmethyl]-piperidin-4-yl}-urea vendor & factory According to the Food and Drug Administration and the Orphan Drug Designation program, orphan status applies to drugs and biologics defined as “those intended for the safe and effective treatment, diagnosis or prevention of rare diseases/disorders that affect fewer than 200,000 people in the US, or that affect more than 200,000 people, ,A CDMO must have bolt-on capabilities with efficient chemistry which translates into adding new capabilities that the specific molecule development may require quickly.